Argen-x N.V.
USPTO PatentsView assignee record - 11 granted patents across 6 technology areas, recorded in grant years 2016–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).
The verdict
According to USPTO PatentsView, Argen-x ranks #23,896 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 6 technology areas.
- #23,896
- of 49,997 US assignees by volume
- 35th percentile
- by Innovation Score (30.8/100)
- 22.6
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R23896 · Foreign Corporation #23,896 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 11 grants
- MID-PACK #23,896/49,997
- PHOTO-FINISH Aquatech International
- CPC-NARROW C07K · 6 areas
- INNOV-THIN 30.8/100
- CLAIMS-DENSE 22.6 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Aquatech International, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Argen-x’s 30.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Argen-x
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Argen-x · this assignee 31
Argen-x · this assignee
31 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Argen-x's Innovation Score is 30.8/100 (35th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Argen-x?
Each dot is one of Argen-x’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Argen-x’s own 22.6 claims/patent is ABOVE the 15.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Argen-x's grants concentrate
Argen-x N.V. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2017 (6 grants) versus a trough of 1 in 2019. By volume, Argen-x sits between Aquatech International, LLC and ARx, LLC.
Who files at Argen-x's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Aquatech Internat…
Aquatech International, LLC
11 patents
- ARC BIO
ARC BIO, LLC
11 patents
- Arch Personal Car…
Arch Personal Care Products L.P.
11 patents
- Arcimoto
Arcimoto, Inc.
11 patents
- Aria Solutions
Aria Solutions, Inc.
11 patents
- Arjowiggins Secur…
Arjowiggins Security
11 patents
- Arkis Biosciences
Arkis Biosciences Inc.
11 patents
- Arx
ARx, LLC
11 patents
- Argen-x ◀
Argen-x N.V.
11 patents
What this shows Argen-x holds 11 patents at rank #23,828, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Argen-x
By rank, the assignees closest to #23,828 in granted patent volume.
- Aquatech International, LLC #23,824 · 11 patents
- ARC BIO, LLC #23,825 · 11 patents
- Arch Personal Care Products L.P. #23,826 · 11 patents
- Arcimoto, Inc. #23,827 · 11 patents
- Aria Solutions, Inc. #23,829 · 11 patents
- Arjowiggins Security #23,830 · 11 patents
- Arkis Biosciences Inc. #23,831 · 11 patents
- ARx, LLC #23,832 · 11 patents
Leaders in C07K (Peptides)
Other assignees with the most granted patents in Argen-x's primary technology class.
- The Regents of the University of California 894 in class
- Regeneron Pharmaceuticals, Inc. 824 in class
- Immatics Biotechnologies GmbH 678 in class
- Genentech, Inc. 565 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 513 in class
- The Trustees of the University of Pennsylvania 501 in class
- Novartis AG 407 in class
- The Board of Trustees of the Leland Stanford Junior University 400 in class
Argen-x's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
31 35th percentile higher than 35% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 18.2% |
| 2017 | 6 | 54.5% |
| 2018 | 2 | 18.2% |
| 2019 | 1 | 9.1% |
Which technologies does Argen-x N.V. patent most?
Top 6 of 6 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Argen-x N.V.'s patent record in context - here's where to go next.
- Argen-x N.V.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
- Ranked #23,896 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Argen-x N.V. against Aquatech International, LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 30.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.